The world of probiotics is undergoing a paradigm shift, and it's all about traceability and functionality. At the Growth Asia Summit 2026, TCI's R&D Manager, Lucas Chang, highlighted the evolution of probiotic delivery from a logistical challenge to a biological one. Instead of just ensuring survival and arrival, the focus is now on understanding the complex interactions between the gut, the body, and the environment. This shift is crucial for addressing the multifaceted nature of aging and its associated pressures.
Chang emphasizes the importance of traceability in the 'evidence chain', which includes microbiome function, bioactive compound production, host response, and measurable impact. Without this traceability, the mechanism of a probiotic's action may remain unclear, especially when it comes to healthy aging. Aging is not a linear process; it involves distinct pressure points that emerge at different stages of life. The body's response to these pressures is what determines our functional trajectory.
One of the key findings from a longitudinal multi-omics study is that the body faces major disruptions around the ages of 40 and 60. These transitions involve changes in lipid metabolism, alcohol metabolism, cardiovascular health, immune regulation, and carbohydrate metabolism. Chang illustrates this point by comparing two individuals of the same chronological age but with different functional trajectories, highlighting the importance of resilience and adaptability in the face of biological challenges.
TCI's approach to tackling these aging stresses is through the development of TCR711, a patented spore-forming probiotic strain. In a study involving adults with non-alcohol fatty liver disease (NAFLD), TCR711 demonstrated a significant improvement in liver-fat outcome compared to a placebo. The study revealed that the gut ecology shifted in response to the probiotic, indicating a broader impact than just the liver. This finding aligns with the idea that fatty liver is linked to changes in microbial metabolic capacity, such as short-chain fatty acids (SCFAs).
The potential of probiotics in addressing aging stresses extends beyond the gut. In another study, participants who supplemented with TCR711 exhibited faster alcohol-clearance signals after consuming a whiskey shot. This was attributed to the strain's alcohol dehydrogenase and aldehyde dehydrogenase capabilities. The study highlights the importance of considering the broader ecosystem and the interconnectedness of biological processes.
Chang also introduces the concept of 'matrix engineering', where the focus is on creating a functional probiotic that not only survives but also performs specific tasks. This approach involves starting with the desired health outcome, tracing the biology backwards, and then designing the probiotic strain, function, and delivery system accordingly. The goal is to create a probiotic that is tailored to the specific needs of the body, rather than forcing a supplement format.
One innovative application of this concept is the development of liquid chocolate containing probiotics. This format not only helps with survival but also integrates probiotics into daily habits. The low free-water, lipid-rich phase and reduced exposure to moisture and oxygen make it an ideal environment for the probiotic strain. Chang suggests that this approach challenges the traditional view of probiotic delivery, demonstrating that the answer can sometimes be found in everyday life rather than solely in supplement formats.
